NICE has said that KardiaMobile 6L can be used in the NHS to measure cardiac QT interval in some adults having or about to have antipsychotic medicines. The NHS is collecting more evidence for this ...

There are 4 ongoing studies assessing KardiaMobile 6L in cardiology settings. The generalisability of these to a psychiatric setting, in people having or about to have antipsychotic medication, is ...

MONTREAL, /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...

LQT-1213 is a first-in-class serum glucocorticoid regulated kinase 1 inhibitor. The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum ...